PerkinElmer Launches Exome Resequencing Service on HiSeq 2000
January 25, 2011
PerkinElmer Launches Exome Resequencing Service on HiSeq 2000
The service, which aims to be profitable within 12 months, plans to attract large academic groups with disease-specific studies, core labs that want to outsource exome sequencing, and research units of pharmaceutical companies. The sequencing lab plans to become CLIA-certified in 2011 and HIPAA-compliant at a later stage.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Exome Sequencing Points to De Novo, Dominant Mutations as the Cause of a Rare, Lethal Disorder
June 1, 2010 / In Sequence - Startup Parabase Genomics Targets Late 2013 Launch for Targeted Sequencing Neonatal Test
October 17, 2012 / Clinical Sequencing News - Cornell Study Shows Targeted Sequencing Can ID Mutations in Advanced Prostate Cancer FFPE Samples
September 19, 2012 / Clinical Sequencing News - GeneDx to Launch Clinical Exome Sequencing Test in Early 2012
October 12, 2011 / Clinical Sequencing News - UMich Center to Offer Clinical Next-Gen Sequencing of Cancer Patients
August 31, 2011 / Clinical Sequencing News